737 related articles for article (PubMed ID: 33617559)
41. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
42. Faecal Carriage of Gram-Negative Multidrug-Resistant Bacteria among Patients Hospitalized in Two Centres in Ulaanbaatar, Mongolia.
Baljin B; Baldan G; Chimeddorj B; Tulgaa K; Gunchin B; Sandag T; Pfeffer K; MacKenzie CR; Wendel AF
PLoS One; 2016; 11(12):e0168146. PubMed ID: 27942042
[TBL] [Abstract][Full Text] [Related]
43. High Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Isolates Recovered in Nigerian Hospitals in 2016 to 2020.
Odih EE; Oaikhena AO; Underwood A; Hounmanou YMG; Oduyebo OO; Fadeyi A; Aboderin AO; Ogunleye VO; Argimón S; Akpunonu VN; Oshun PO; Egwuenu A; Okwor TJ; Ihekweazu C; Aanensen DM; Dalsgaard A; Okeke IN
mSphere; 2023 Jun; 8(3):e0009823. PubMed ID: 37067411
[TBL] [Abstract][Full Text] [Related]
44. Co-existence of
Joshi PR; Acharya M; Kakshapati T; Leungtongkam U; Thummeepak R; Sitthisak S
Antimicrob Resist Infect Control; 2017; 6():21. PubMed ID: 28191309
[TBL] [Abstract][Full Text] [Related]
45. Molecular and genetic characterization of carbapenemase-producing bacteria in Venezuela.
Gomez-Gamboa L; Barrios-Camacho H; Duran-Bedolla J; Sánchez-Perez A; Reyna-Flores F; Perozo-Mena A; Zabala I; Rodriguez-Medina N; Martínez-Barnetche J; Téllez-Sosa J; Valdovinos-Torres H; Garza-Ramos U
J Chemother; 2019 Oct; 31(6):349-353. PubMed ID: 31046636
[TBL] [Abstract][Full Text] [Related]
46. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
47. Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil.
Dias VC; Diniz CG; Peter AC; Bastos AN; Bastos VQ; Bastos LQ; Da Silva VL
J Infect Dev Ctries; 2016 Jun; 10(6):544-53. PubMed ID: 27367001
[TBL] [Abstract][Full Text] [Related]
48. Genomic epidemiology of carbapenemase-producing Gram-negative bacteria at the human-animal-environment interface in Djibouti city, Djibouti.
Mohamed HS; Galal L; Hayer J; Benavides JA; Bañuls AL; Dupont C; Conquet G; Carrière C; Dumont Y; Didelot MN; Michon AL; Jean-Pierre H; Aboubaker MH; Godreuil S
Sci Total Environ; 2023 Dec; 905():167160. PubMed ID: 37730061
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of Carbapenem Resistance Mechanisms Among Gram-Negative Pathogens in Lebanon: Results of the First Cross-Sectional Countrywide Study.
Hammoudi Halat D; Moubareck CA; Sarkis DK
Microb Drug Resist; 2017 Sep; 23(6):733-743. PubMed ID: 28080212
[TBL] [Abstract][Full Text] [Related]
50. Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China.
Li S; Duan X; Peng Y; Rui Y
BMC Infect Dis; 2019 Oct; 19(1):900. PubMed ID: 31660862
[TBL] [Abstract][Full Text] [Related]
51. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
52. Emergence of armA and rmtB genes among VIM, NDM, and IMP metallo-β-lactamase-producing multidrug-resistant Gram-negative pathogens.
Gopalakrishnan S; Kamalanathan A; Rajan S; Bhagat VM; Ali MKS
Acta Microbiol Immunol Hung; 2018 Mar; 65(1):107-118. PubMed ID: 28870092
[TBL] [Abstract][Full Text] [Related]
53. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
[TBL] [Abstract][Full Text] [Related]
54. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].
Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F
Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275
[TBL] [Abstract][Full Text] [Related]
55. Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase.
Abdelaziz NA
Antimicrob Resist Infect Control; 2022 Jan; 11(1):13. PubMed ID: 35063019
[TBL] [Abstract][Full Text] [Related]
56. Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
Vanegas JM; Parra OL; Jiménez JN
BMC Infect Dis; 2016 Sep; 16(1):463. PubMed ID: 27585707
[TBL] [Abstract][Full Text] [Related]
57. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
Mataseje LF; Bryce E; Roscoe D; Boyd DA; Embree J; Gravel D; Katz K; Kibsey P; Kuhn M; Mounchili A; Simor A; Taylor G; Thomas E; Turgeon N; Mulvey MR;
J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
59. A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes.
Manandhar S; Zellweger RM; Maharjan N; Dongol S; Prajapati KG; Thwaites G; Basnyat B; Dixit SM; Baker S; Karkey A
Ann Clin Microbiol Antimicrob; 2020 Oct; 19(1):48. PubMed ID: 33087115
[TBL] [Abstract][Full Text] [Related]
60. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
